Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dermtech Inc (NQ: DMTK )

2.850 +0.030 (+1.06%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dermtech Inc

< Previous 1 2 3 4 5 6 Next >
3 Things About DermTech That Smart Investors Know
These three facts can help you determine whether you want in on this fast-growing company. 
Via The Motley Fool
DermTech Presents in Expert Panel at Inaugural Alliance for Innovation in Integrated Healthcare Summit
From DermTech
Via Business Wire
DermTech Announces New Appointment of L’Oréal USA Leader Nathalie Gerschtein Keraudy to its Board of Directors
From DermTech, Inc.
Via Business Wire
DermTech Sponsors San Diego Open; Partners with Tennis Pro Brandon Nakashima to Raise Awareness for Sun Safety
From DermTech, Inc.
Via Business Wire
Recap: DermTech Q2 Earnings
Shares of DermTech (NASDAQ:DMTK) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 1.72% over the past year to ($0... 
Via Benzinga
How DermTech Could Change Skin Cancer Testing -- Or Fizzle Out
DermTech's innovative skin treatment is making it easier and cheaper to test for skin cancer, causing the business to grow. Fast. 
Via The Motley Fool
DermTech Study, “Non-Invasive Detection of Genomic Atypia Increases Real-World NPV and PPV of the Melanoma Diagnostic Pathway and Reduces Biopsy Burden,” Published in SKIN: The Journal Of Cutaneous Medicine
From DermTech, Inc.
Via Business Wire
Should Investors Be Concerned About DermTech?
Be concerned? No. Be patient? Yes. 
Via The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
Their growth prospects are massive. 
Via The Motley Fool
DermTech Management to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
From DermTech, Inc.
Via Business Wire
DermTech to Present at Florida Association of Health Plans 2021 Annual Conference
From DermTech, Inc.
Via Business Wire
DermTech Management to Participate at the Lake Street 2021 BIG5 Conference
From DermTech, Inc.
Via Business Wire
Looking into DermTech's Return on Capital Employed
Pulled from Benzinga Pro data DermTech (NASDAQ:DMTK) reported Q2 sales of $3.12 million. Earnings fell to a loss of $17.31 million, resulting in a 29.03% decrease from last... 
Via Benzinga
Why Shares of DermTech Dropped 19% in July
The company's noninvasive skin genomics platform has great potential, but its losses have made investors wary. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Scopus BioPharma (NASDAQ:SCPS) s... 
Via Benzinga
DermTech Reports Second Quarter 2021 Financial Results
From DermTech, Inc.
Via Business Wire
DermTech to Announce Second Quarter Financial Results on August 4, 2021
From DermTech, Inc.
Via Business Wire
99 Biggest Movers From Yesterday
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a... 
Via Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Exposures Product Safety
DermTech Announces New San Diego Headquarters
From DermTech, Inc.
Via Business Wire
This Medical Device Company Is Changing the Game in Skin Cancer
And it's on sale right now. 
Via The Motley Fool
Cramer Weighs In On FireEye, 3D Systems, More
On CNBC's "Mad Money Lightning Round," Jim Cramer revealed he prefers Crowdstrike Holdings Inc (NASDAQ: CRWD), Zscaler Inc (NASDAQ: ZS) and Palo Alto Networks Inc (... 
Via Benzinga
DermTech Announces New Appointment of Monica Tellado to its Board of Directors
From DermTech, Inc.
Via Business Wire
DermTech CEO John Dobak, M.D. Wins San Diego Business Journal CEO of the Year Award, Public Company, Medium Category
From DermTech, Inc.
Via Business Wire
DermTech to Partner with University of Barcelona for Research Study on Atopic Dermatitis and Psoriasis
From DermTech, Inc.
Via Business Wire
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19
DermTech Announces Three New Key Leadership Appointments: Chief Medical Officer, Vice President, Sales and Vice President, Information Technology and Digital Systems
From DermTech, Inc.
Via Business Wire
DermTech Announces Three New Scientific Advisory Board Members
From DermTech, Inc.
Via Business Wire
8 Stocks With The Highest Short Percent Of Float Right Now
Traders often look at short interest to get a sense of how many people are bearish on a stock and how strong the possibility of a short squeeze is. But simply looking at the size... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.